Sunovion Pharmaceuticals Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
2,400
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.86B
Sunovion Pharmaceuticals General Information
Description
Provider of medical therapies designed to contribute to society through value creation based on research and development activities for the betterment of health care and fuller lives of people worldwide. The company's innovative therapies address serious psychiatric, neurological, and respiratory conditions, enabling people with serious medical conditions to lead fulfilling lives.
Contact Information
Website
www.sunovion.comCorporate Office
- 84 Waterford Drive
- Marlborough, MA 01752
- United States
Corporate Office
- 84 Waterford Drive
- Marlborough, MA 01752
- United States
Sunovion Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 20-Oct-2009 | $2.86B | Completed | Generating Revenue | ||
| 2. IPO | 20-Sep-1991 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-1985 | Completed | Startup |
Sunovion Pharmaceuticals Comparisons
Industry
Financing
Details
Sunovion Pharmaceuticals Competitors (21)
One of Sunovion Pharmaceuticals’s 21 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| ViiV Healthcare | Corporate Backed or Acquired | London, United Kingdom | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Alvogen Group | Formerly PE-Backed | Morristown, NJ | ||||
| Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany |
Sunovion Pharmaceuticals Patents
Sunovion Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210179561-A1 | Acid addition salts of apomorphine, pharmaceutical compositions containing the same, and methods of using the same | Inactive | 23-Aug-2018 | ||
| AU-677805-C | Enantioselective production of chiral carboxylic acids | Inactive | 26-Oct-1992 |
Sunovion Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sunovion Pharmaceuticals Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Domain Associates | Venture Capital | Minority | ||
| Glynn Capital | Venture Capital | Minority | ||
| Johnston Associates | Venture Capital | Minority | ||
| New Enterprise Associates | Venture Capital | Minority | ||
| SR One | Corporate Venture Capital | Minority |
Sunovion Pharmaceuticals Investments & Acquisitions (7)
Sunovion Pharmaceuticals’s most recent deal was a Later Stage VC with Elixirgen Therapeutics for . The deal was made on 17-Feb-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Elixirgen Therapeutics | 17-Feb-2021 | Later Stage VC | Drug Discovery | ||
| Cynapsus | 21-Oct-2016 | Merger/Acquisition | Drug Discovery | ||
| Sunovion Respiratory Development | 05-Sep-2012 | Merger/Acquisition | Drug Discovery | ||
| Sepracor Pharmaceuticals | 04-Jun-2008 | Merger/Acquisition | Pharmaceuticals | ||
| ACADIA Pharmaceuticals | 17-Jan-2006 | PIPE | Pharmaceuticals |
Sunovion Pharmaceuticals FAQs
-
When was Sunovion Pharmaceuticals founded?
Sunovion Pharmaceuticals was founded in 1984.
-
Where is Sunovion Pharmaceuticals headquartered?
Sunovion Pharmaceuticals is headquartered in Marlborough, MA.
-
What is the size of Sunovion Pharmaceuticals?
Sunovion Pharmaceuticals has 2,400 total employees.
-
What industry is Sunovion Pharmaceuticals in?
Sunovion Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Sunovion Pharmaceuticals a private or public company?
Sunovion Pharmaceuticals is a Private company.
-
What is the current valuation of Sunovion Pharmaceuticals?
The current valuation of Sunovion Pharmaceuticals is .
-
What is Sunovion Pharmaceuticals’s current revenue?
The current revenue for Sunovion Pharmaceuticals is .
-
Who are Sunovion Pharmaceuticals’s investors?
Domain Associates, Glynn Capital, Johnston Associates, New Enterprise Associates, and SR One are 5 of 6 investors who have invested in Sunovion Pharmaceuticals.
-
Who are Sunovion Pharmaceuticals’s competitors?
Johnson&Johnson Innovative Medicine, ViiV Healthcare, Astellas Pharma, Alvogen Group, and Boehringer Ingelheim are some of the 21 competitors of Sunovion Pharmaceuticals.
-
When was Sunovion Pharmaceuticals acquired?
Sunovion Pharmaceuticals was acquired on 20-Oct-2009.
-
Who acquired Sunovion Pharmaceuticals?
Sunovion Pharmaceuticals was acquired by Sumitomo Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
